Biogen Idec Inc.

biogen idec inc. - All News and Analysis

• Spending and Board Oversight Irk Some Elan Investors

  Reuters - 2008-12-10

  BOSTON (Reuters) - It's not just a slowing growth of its main product and an 80 percent stock decline in five months that has some big investors in Irish drugmaker Elan ELNELN riled up.The company's board is under fire by some large shareholders to increase its oversight over what they...

  Tags: Board, Jet, Investor, CEO, Elan, Biogen Idec Inc., Elan Corp. Plc., Kinsale, Wyeth

• Biogen Reports Another Tysabri Glitsch

  Seeking Alpha - 2008-10-30

  Mike Havrilla submits: click to enlarge After the market close, Biogen BIIB filed an 8-K with the SEC reporting a new case of the potentially fatal brain disease known as PML or progressive multifocal leukoencephalopathy in a patient receiving their multiple sclerosis [MS] drug Tysabri, adding to the two new...

  Tags: Biogen Idec Inc., Seeking Alpha, Mike Havrilla, Elan Corp. Plc., Healthcare

• Zacks Analyst Blog Highlights: Peabody Energy Corp., Pfizer Inc., SanDisk Corp., Everest Re Group, Ltd. and Biogen Idec Inc

  - 2008-10-23

  CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Peabody Energy Corp. (NYSE: BTU), Pfizer Inc. (NYSE: PFE), SanDisk Corp....

  Tags: Biogen Idec Inc., blog, FINANCE, Investment, MARKETING, Nasdaq Stock Market Inc., New York Stock Exchange, newsletter, Peabody Energy Corp., Pfizer Inc., SanDisk Corp., stock

• Tysabri Concerns Continue to Weigh on Biogen, Elan

  Seeking Alpha - 2008-10-23

  EP Vantage submits: Despite reporting strong quarterly revenues and earnings ahead of Wall Street estimates, shares in Biogen Idec BIIB fell 7% Tuesday and continued to fall in yesterday, down even further to a two-year low of $40.72. With shares in one of Biogen Idec’s key partners, Elan ELN,...

  Tags: Biogen Idec Inc., Seeking Alpha, EP Vantage, Elan Corp. Plc., Biotech, Healthcare

• Biogen Idec Inc. Q3 2008 Earnings Conference Call Transcript

  Seeking Alpha - 2008-10-21

  Question-and-Answer SessionYour first question comes from Mark Schoenebaum with Deutsche Bank. Mark Schoenebaum - Deutsche Bank Okay. Thank you for taking my question guys. I am going to ask question for everyone in the queue is having to top of the list. Is it possible for you to give...

  Tags: Patient, Holiday, Physician, Call Transcript, Biogen Idec Inc., Earnings, Seeking Alpha

• Earnings Preview: Biogen Idec

  Seeking Alpha - 2008-10-20

  Biogen Idec BIIB is expected to report Q3 earnings Tuesday Oct. 21 before market open, with a conference call scheduled for 8:30 am ET. Guidance Analysts are looking for a profit of 89c on revenue of $1.01B. The consensus is 80c to 95c for EPS, and revenue of $968M to...

  Tags: Revenue, Biogen Idec Inc., Earnings, Seeking Alpha, Financial Accounting, Operational Accounting, Finance, theflyonthewall.com, Biotech

• Zacks Analyst Blog Highlights: Biogen Idec, Inc., Royal Bank of Scotland Group Plc., Lloyds TSB Group Plc., HBOS Plc. and Strayer Education, Inc

  - 2008-10-14

  CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Biogen Idec, Inc. (Nasdaq: BIIB), Royal Bank of Scotland Group Plc....

  Tags: Biogen Idec Inc., blog, FINANCE, HBOS Plc., Investment, MARKETING, Nasdaq Stock Market Inc., New York Stock Exchange, newsletter, stock

• Drug Safety Updates For Elan, Biogen, Amylin, and Lilly

  Seeking Alpha - 2008-08-27

  Mike Huckman submits: After the closing bell Monday, Eli Lilly LLY and Amylin Pharmaceuticals AMLN announced that they're going to hold a conference call for analysts and investors about their diabetes drug Byetta. Last week, the Food and Drug Administration revealed that six patients on the drug had to...

  Tags: Biogen Idec Inc., Biotech, Healthcare, Amylin Pharmaceuticals Inc., Elan Corp. Plc., Eli Lilly & Co.

• Three Biotech ETFs: A Way To Follow the 'Smart Money' into Healthcare

  Seeking Alpha - 2008-08-15

  Trader Mark submits: One area you can see I've been transitioning into is healthcare. I still don't buy the "technology is a safe haven" thesis, but I have to respect that's where money flow is going. Healthcare I can feel a bit more comfortable with because it's a...

  Tags: ETF, Affymetrix, Biogen Idec Inc., Genentech Inc., Gilead Sciences Inc., Illumina Inc.

• Icahn Boosts Stake in Biogen Idec to 6% Following TYSABRI Sell-Off

  Seeking Alpha - 2008-08-13

  Lon Juricic submits: In a 13D filing on Biogen Idec BIIB, Carl Icahn disclosed he raised his stake in the company to 6.03% (17,511,304 shares). This is up from the 9,948,723 share stake held at the quarter ended 3/31/08. Icahn noted that his representatives have had, and from...

  Tags: Biogen Idec Inc., Biotech

• Biogen-Idec, Elan: Panic Selling Creates Interesting Opportunity

  Seeking Alpha - 2008-08-10

  A. Reza Saadat submits: In July, Biogen-Idec BIIB and Elan ELN, who co-market the multiple sclerosis drug Tysabri, announced two new cases of PML, a potentially deadly side effect. The stocks sold-off almost entirely. Biogen-Idec lost about 30% of its market share while Elan has lost over two thirds...

  Tags: Biotech, Biogen Idec Inc., Elan Corp. Plc.

• Icahn Favorites Have Abysmal Month

  Seeking Alpha - 2008-08-08

  Steve Farrington submits: After the Yahoo! YHOO debacle that had us watching his every move this summer, August has not gotten off to the best start for the billionaire, either. Blockbuster, Inc. BBI posted a larger than expected 2nd quarter loss lead by low DVD rental margins. The...

  Tags: US Market, Blockbuster Inc., Biogen Idec Inc., Yahoo! Inc.

• Stock Performance Since Earnings

  Seeking Alpha - 2008-08-06

  Hickey and Walters Bespoke submit: We recently calculated the performance of all US stocks since the open following their most recent earnings reports.  This takes out the initial reaction to earnings reports in after-hours and pre-market trading and highlights how investors have treated shares post earnings.  As shown...

  Tags: US Market, AuthenTec, Biogen Idec Inc., Continental Airlines Inc., CDI Corp., Centene Corp., Commercial Vehicle Group Inc., Elan Corp. Plc., EPIQ Systems Inc., Freeport-McMoRan Copper & Gold Inc., Great Atlantic & Pacific Tea Company Inc., Gramercy Capital Corp., ImClone Systems Inc., Overstock.com Inc., Piper Jaffray Cos., Penson Worldwide Inc., Spartan Motors Inc., SunTrust Banks Inc., Trimas Corp., Wachovia Corp.

• Zacks Analyst Interview Highlights: Genentech, Biogen Idec, Gilead, Celgene and Pfizer

  - 2008-08-01

  CHICAGO -- Zacks.com releases the latest Analyst Interview. Today's interview is with senior analyst Jason Napodano, who discusses Genentech (NYSE: DNA), Biogen Idec (Nasdaq: BIIB), Gilead (Nasdaq: GILD), Celgene (Nasdaq: CELG) and Pfizer (NYSE: PFE). Get the most recent insight from Zacks Equity Research with the free Profit from...

  Tags: Biogen Idec Inc., Biotechnology, Celgene Corp., FINANCE, Genentech Inc., Investment, MARKETING, Nasdaq Stock Market Inc., New York Stock Exchange, newsletter, Pfizer Inc., stock

• Friday Options Update: ELN, BIIB, ANR, ORCL, MAR, A, IP, HBC, RKH

  Seeking Alpha - 2008-08-01

  Rebecca Engmann Darst contributed to this report. Elan ELN  - “Weekus horribilis” for drugmaker Elan took hold today after its multiple-sclerosis drug Tysabri was implicated in new cases of a lethal brain infection. Coming hot on the heels of another product disappointment – underwhelming data on a much hoped-for Alzheimer’s...

  Tags: Oracle Corp., Marriott International Inc., International Paper Co., HSBC Holdings Plc., Elan Corp. Plc., Biogen Idec Inc., Alpha Natural Resources Inc., Agilent Technologies Inc., US Market

• Biogen IDEC, Inc. Q2 2008 Earnings Call Transcript

  Seeking Alpha - 2008-07-22

  Question-and-Answer Session[Operator Instructions]. Your first question is from Michael Aberman with Credit Suisse. Michael Aberman - Credit Suisse Fantastic. Thanks guys for taking the question. I am wondering if you could give me a little... a more detailed update on your pipeline, in particular late stage programs, Lixivaptan, BG-12,...

  Tags: Biogen Idec Inc.

• Proxy Governance Endorses All Four Biogen Idec Director Nominees

  - 2008-06-11

  All Three Leading Voting Advisory Services Recommend Stockholders Vote FOR Company Nominees on the WHITE Proxy Card

  Tags: Biogen Idec Inc., nominee

• RiskMetrics and Glass Lewis Endorse All Four Biogen Idec Director Nominees

  - 2008-06-10

  Two Leading Voting Advisories Recommend Company Stockholders Vote FOR Company Nominees on the WHITE Proxy Card

  Tags: Biogen Idec Inc., Company

• Biogen Idec Names Hans Peter Hasler Chief Operating Officer

  - 2008-05-29

  CAMBRIDGE, Mass. -- Biogen Idec (Nasdaq: BIIB) today named Hans Peter Hasler Chief Operating Officer COO of the company. Mr. Hasler, age 52, has served as Executive Vice President, Global Neurology and Head of International. In his new role, Mr. Hasler will oversee all commercial operations as well as the...

  Tags: Biogen Idec Inc.

• MEMOTEXT(R) and BioGen Idec Canada Announce Ground-Breaking Partnership to Help MS Patients

  - 2008-05-26

  Patients with Multiple Sclerosis MS who take the once-a-week prescription injection AVONEX® (interferon beta-1a) will now be the first in North America to benefit from a free and unique adherence solution program. BioGen Idec Canada, a subsidiary of Biogen Idec Inc., makers of AVONEX, and MEMOTEXT®, provider of personalized adherence...

  Tags: Biogen Idec Inc., Microsoft Corp., patient

• Incorporated: 1985
• CEO: Mr. James C. Mullen